BI 655064

CD40 ligand ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34624444 An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases. 2021 Nov 20 1
2 30902820 Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. 2019 Jun 2
3 29127458 Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases. 2018 Feb 2
4 30113724 Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BIĀ 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune Diseases. 2018 Dec 1